Takeshima, K., Hayashida, T., Maeda, H., Nakashoji, A., Yokoe, T., Seki, T., . . . Kitagawa, Y. (2020). Increased frequency of ESR1 mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitor. Oncol Lett.
Citación estilo ChicagoTakeshima, Kaoru, Tetsu Hayashida, Hinako Maeda, Ayako Nakashoji, Takamichi Yokoe, Tomoko Seki, Maiko Takahashi, y Yuko Kitagawa. "Increased Frequency of ESR1 Mutation in Metastatic Breast Cancer By Dosing Selective Estrogen Receptor Modulator Followed By Aromatase Inhibitor." Oncol Lett 2020.
Cita MLATakeshima, Kaoru, et al. "Increased Frequency of ESR1 Mutation in Metastatic Breast Cancer By Dosing Selective Estrogen Receptor Modulator Followed By Aromatase Inhibitor." Oncol Lett 2020.